| scholarly article | Q13442814 |
| P50 | author | Joseph I Wolfsdorf | Q92171021 |
| Ernst J. Schaefer | Q124678742 | ||
| P2093 | author name string | David A Weinstein | |
| Sakine Sever | |||
| Reyhan Gedik | |||
| P2860 | cites work | Severe iron deficiency anemia in transgenic mice expressing liver hepcidin | Q24536163 |
| Natural history of hepatocellular adenoma formation in glycogen storage disease type I | Q24633522 | ||
| Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease | Q28209487 | ||
| Molecular genetics of type 1 glycogen storage disease | Q34270143 | ||
| Glycogen storage diseases | Q35078487 | ||
| Hepcidin and anaemia. | Q35926346 | ||
| Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers | Q37130819 | ||
| Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. | Q37218814 | ||
| Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. | Q37299889 | ||
| Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control | Q37321396 | ||
| Marked HDL deficiency and premature coronary heart disease. | Q37771219 | ||
| Inborn errors of carbohydrate metabolism | Q37801089 | ||
| Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. | Q41344681 | ||
| High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study | Q45075456 | ||
| Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. | Q46562134 | ||
| Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women | Q57308696 | ||
| Hepcidin and the anemia of chronic disease | Q82660862 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| glycogen storage disease | Q1421738 | ||
| triglyceride | Q186319 | ||
| glycogen metabolic process | Q14902477 | ||
| P304 | page(s) | 596-600 | |
| P577 | publication date | 2012-08-30 | |
| P1433 | published in | Journal of Clinical Lipidology | Q15817174 |
| P1476 | title | Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism | |
| P478 | volume | 6 |
| Q27683761 | Crystal structure of lipid phosphatase Escherichia coli phosphatidylglycerophosphate phosphatase B |
| Q91097968 | Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases |
| Q38160330 | Hepatic glucose sensing and integrative pathways in the liver |
| Q88762967 | Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases |
| Q90457188 | Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy |
Search more.